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Emergency department charges may be
associated with mortality in patients with
severe sepsis and septic shock: a cohort
study
Nicholas M. Mohr1,2, Ryan Dick-Perez1,2* , Azeemuddin Ahmed1, Karisa K. Harland1, Dan Shane3, Daniel Miller1,
Christine Miyake4, Levi Kannedy1, Brian M. Fuller5 and James C. Torner6
Abstract
Background: Sepsis severity of illness is challenging to measure using claims, which makes sepsis difficult to study
using administrative data. We hypothesized that emergency department (ED) charges may be associated with
hospital mortality, and could be a surrogate marker of severity of illness for research purposes. The objective of this
study was to measure concordance between ED charges and mortality in admitted patients with severe sepsis or
septic shock.
Methods: Cohort study of all adult patients presenting to a 60,000-visit Midwestern academic ED with severe sepsis
or septic shock (by ICD-9 codes) between July 1, 2008 and June 30, 2010. Data on demographics, admission
APACHE-II score, and disposition was extracted from the medical record, and comorbidities were identified from
diagnosis codes using the Elixhauser methodology. Summary statistics were reported and bivariate concordance
was tested using Pearson correlation. Logistic regression models for 28-day mortality were developed to measure
the independent association with mortality.
Results: We included a total of 294 patients in the analysis. We found that ED charges were inversely related to mortality
(adjusted OR 0.829 per $1000 increase in total ED charges, 95%CI 0.702–0.980). ED charges were also independently
associated with 28-day hospital-free and ICU-free days (0.74 days increase per $1000 additional ED charges, 95%CI 0.06–1.41
and 0.81 days increase per $1000 additional ED charges, 95%CI 0.05–1.56, respectively). ED charges were also associated with
APACHE-II score ($34 total ED charges per point increase in APACHE-II score, 95%CI $6–62).
Conclusions: ED charges in administrative data sets are associated with in-hospital mortality and health care utilization, likely
related to both illness severity and intensity of early sepsis resuscitation. ED charges may have a role in risk adjustment
models using administrative data for acute care research.
Keywords: Sepsis, Health services research, Costs and cost analysis, Risk adjustment, Emergency service, hospital, Critical
illness
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Background
Administrative data sets are an increasingly important tool
for conducting population-based and health services research
as they contain detailed information about medical care and
outcomes [1]. Administrative data sets allow for rapid identi-
fication of a large cohort of patients, and they facilitate study
across medical centers and health systems [2]. While health
services studies using administrative data in sepsis and crit-
ical care exist [3, 4], it has been challenging to perform rigor-
ous analyses because no robust physiologic measure of
illness severity is captured in hospital claims [5]. Therefore
there remains a need for a validated method to adjust for se-
verity of illness based on administrative data.
Sepsis is responsible for 17% of US in-hospital deaths,
and nearly one-half of sepsis admissions are treated in the
emergency department (ED) [6, 7]. Age, medical comorbid-
ities, admission diagnosis, and surgical status impact mor-
bidity and mortality significantly, so risk adjustment models
are critical to compare outcomes across clinical sepsis stud-
ies [8]. Illness severity scores, such as the Acute Physiology
and Chronic Health Evaluation, 2nd edition (APACHE-II)
score [9], the Simplified Acute Physiology Score (SAPS),
and the Sequential Organ Failure Assessment (SOFA) score
are valid scoring systems for critically ill patients [10–12],
but the parameters used to calculate these scores are not
captured in claims.
The objective of this study is to measure the con-
cordance between ED charges and mortality in pa-
tients admitted with severe sepsis or septic shock,
with a secondary objective of measuring the associ-
ation between ED charges and APACHE-II score.
We hypothesize that intensity of care is closely re-
lated to severity of illness, and that level of intensity
could be approximated by ED charges. If validated,
ED charges could be a useful covariate for claims-




This study was a cohort study of all adult (age ≥ 18
years) patients presenting to a Midwestern academic
60,000-visit ED with severe sepsis or septic shock
between July 1, 2008 and June 30, 2010. Severe sep-
sis and septic shock were defined by International
Classification of Diseases, 9th Edition (ICD-9) hos-
pital discharge diagnosis codes (995.92 or 785.52),
evidence of infection during the index ED visit, and
admission to the intensive care unit (ICU) during
the hospital stay. Patients who had surgery per-
formed were excluded from the data set. The study
was approved by the local institutional review board
(University of Iowa IRB-001, reference number
201211702) under waiver of informed consent.
Study protocol
After charts were identified by ICD-9 criteria, a study in-
vestigator (CM) manually reviewed each medical record
to confirm that the study subjects had infection in the
ED. Then a research assistant, blinded to the study hy-
pothesis, reviewed each medical record to abstract data
using a standardized case report form. We collected data
on demographics, source of infection, APACHE-II score
at hospital admission, and final disposition. Two data
sets were used in the study, clinical data to calculate the
APACHE-II scores and administrative data set to extract
ED charges and hospital discharge diagnosis codes.
Professional fees and hospital facility charges were
maintained as separate variables. Comorbidities were de-
fined from billing discharge diagnosis codes using the
Elixhauser methodology, which defines a set of 30 condi-
tions associated with clinical outcomes and health care
utilization [13]. For calculation of APACHE-II scores, we
used laboratory and vital sign values from the medical rec-
ord, and we assumed laboratory values that were not mea-
sured were normal. We recorded hospital mortality and
28-day hospital-free and ICU-free days, which we defined
as the number of days in the first 28 days after admission
that a patient spent alive outside the hospital and the ICU,
respectively. Using this measurement for length-of-stay is
frequently done in studies of the critically ill to accurately
account for censored data among non-survivors.
Outcomes
The primary outcome of the study was concordance be-
tween ED charges and mortality. Secondary outcomes in-
cluded the association between ED charges, APACHE-II
score, and Elixhauser comorbidities with hospital survival
and hospital length-of-stay (measured as 28-day hospital-
free and ICU-free days).
Analysis
We performed summary statistics using the Student’s
t-test, the Wilcoxon rank-sum test, and the chi-squared
test, as appropriate. We used Pearson correlation coeffi-
cient to describe bivariate concordance between ED
charges and APACHE-II score. Each analysis was con-
ducted with total ED charges, ED professional fees, and
ED facility charges separately, and the charge with the
strongest association with APACHE-II score was used in
subsequent charge-based analyses.
Next, a logistic regression model was developed using the
primary outcome of hospital mortality. Three separate
models were constructed and compared using the Bayesian
Information Criterion (BIC): one had APACHE-II score as a
single predictor, the second had ED charges as a single pre-
dictor, and the third had the Elixhauser comorbidity variables
reduced to its most parsimonious model. A subsequent lo-
gistic regression model was developed that included both
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APACHE-II score and ED charges, hoping to understand
whether ED charges provided additional predictive power
beyond that available with APACHE-II score alone.
Each continuous predictor was initially modeled as a
categorical variable by dividing it into quintiles to test
the assumption that the predictors were linearly associ-
ated with mortality. Once this assumption was con-
firmed, the final models used the original continuous
variable as the predictor, if appropriate. These models
were compared using the area under the curve (AUC) of
the receiver operator characteristics analysis to compare
the relative explanatory power of each index in predict-
ing hospital survival.
For the secondary analysis, univariate linear regression
models were constructed to measure the association be-
tween APACHE-II score and ED charges (separately) with
28-day hospital-free days and with 28-day ICU-free days.
We completed all analysis using Stata v. 13.1 (Stata-
Corp, College Station, TX), and all results are reported
using the Strengthening the Reporting of Observational
Studies in Epidemiology (STROBE) guidelines [14].
Availability of data and materials
Because the data used for this analysis included identifi-
able protected health information, the original data set is
not available for release.
Results
During the 2-year study period, 294 patients were included
in the analysis, and 83 (28%) died. Table 1 shows the demo-
graphics, ED interventions, comorbidities and baseline vitals.
The median APACHE-II score was 17 (rang 2 to 47), and
the median ED charge was $3640 (IQR $2861 - $5234).
Mortality
ED charges were significantly associated with mortality,
with higher ED charges being associated with lower mor-
tality (adjusted OR 0.829 per $1000 total ED charges,
95%CI 0.702–0.980).
Severity of illness
Illness severity and ED charges were also associated (p =
0.016), with every point increase in APACHE-II score as-
sociated with a $34 (95% CI $6–62) increase in ED
charges (Fig. 1). Of the total ED charges, both hospital
charges ($20 per point increase in APACHE-II score,
95%CI $3–37) and professional fees ($14 per point in-
crease in APACHE-II score, 95%CI $2–26) were corre-
lated with APACHE-II score.
Prediction of mortality
Elixhauser comorbidities, APACHE-II score, and ED charges
all independently predict 28-day mortality (p < 0.001, p=
0.010, p= 0.028). Elixhauser comorbidities predicted
mortality well (AUC= 0.729), while APACHE-II score and
ED charges were significant but poor in their predictive
value (AUC= 0.575 and AUC= 0.596, respectively) (Fig. 2).
Both APACHE-II and ED charges were linearly related to
mortality.
Prediction of length-of-stay
ED charges were independently associated with 28-day
hospital-free days (0.74 days increase in 28-day hospital-free
days per $1000 additional ED charges, 95%CI 0.06–1.41)
and 28-day ICU-free days (0.81 days increase in 28-day
ICU-free days per $1000 additional ED charges, 95%CI
0.05–1.56). APACHE score was the stronger predictor of
both hospital and ICU-free days (BIC 2188 vs. 2193 for
hospital-free days, BIC 2254 vs. 2259 for ICU-free days).
Discussion
The ability to adjust for severity of illness is important in
comparing clinical outcomes such as mortality and
length-of-stay in observational health services analyses,
but this adjustment has been elusive for administrative
analyses of sepsis studies. The APACHE-II score is a ro-
bust and well-validated tool that can be used to predict
mortality, and it is commonly used when comparing health
care outcomes for critically ill patients [10]. Physiologic and
laboratory data are often unavailable in health services ana-
lyses that are conducted using administrative claims data,
which limits severity adjustment in these studies [15]. This
study identifies ED charges as a potential surrogate meas-
ure, suggesting that it can be used as a covariate in
outcomes-based sepsis studies using administrative claims,
even when more robust physiologic severity of illness mea-
sures are not available.
ED charges are usually viewed as an outcome related to
care provided, but they are also a reflection of the amount
and type of care needed during an ED stay. In the United
States, ED charges are generated from professional fees and
facility fees, and charges performed during the study period
were performed on a fee-for-service basis. These fees are
based on the time that health care providers spend caring
for a patient, separately billable procedures that are per-
formed (e.g., central venous line placement, endotracheal
intubation), and the medical complexity documented. All
severity of illness indices are surrogate markers for the
probability of death assessed at admission [9]. These
markers are designed to allow for risk adjustment to meas-
ure the probability of death attributable to only conditions
recognized at the time of hospital admission, and ED
charges were hypothesized to function similarly. Patients
who are more seriously ill (hypotensive, requiring intub-
ation, or needing more time and resource-intensive care)
also receive higher hospital bills, and that relationship was
validated in our model.
Mohr et al. BMC Emergency Medicine           (2018) 18:62 Page 3 of 6
In addition to finding that ED charges are related to
mortality, however, the decreased mortality was found
with higher charges. This finding might indicate that
care delivered in the ED (measured by charges) may also
be influencing outcomes. Early aggressive ED sepsis care
has been shown to decrease mortality [16], and the
higher ED charges may be capturing the impact of ag-
gressive appropriate resuscitation. This finding suggests
that ED charges may be included in studies of non-ED
interventions on sepsis outcomes, because controlling
for ED charges may capture both the effect of severity of
illness and treatment effects of ED care.
This study introduces ED charges as a predictor of
clinical outcomes when physiologic severity of illness
scores are not available retrospectively for research
purposes. There are many areas of acute care research
that may benefit from adjusting for ED charges as a
marker of disease severity. Studies of diseases where
acute disease severity strongly influences outcomes, such
as sepsis, acute respiratory failure, stroke, and trauma
may benefit from such an adjustment. Although these
data only inform the use of ED charges in sepsis studies,
other future studies should consider ED charges for its
predictive value. In this way, ED charges can be treated
as a nuisance variable – a variable that may be associ-
ated with a potentially confounding variable, but where
the magnitude of effect is irrelevant in itself. There may
also be other non-critical care diseases where this adjust-
ment may also be useful, such as asthma or congestive
heart failure.
Table 1 Demographics and ED care for patients in study cohort. Baseline characteristics of the study population
Factor All Patients (n = 294) Survivors (n = 211) Non-survivors (n = 83) Difference (95%CI)
Male, n (%) 163 (55) 121 (57) 42 (51) 6.7 (− 6.0–19.4)
Age, mean (SD) 58.0 (16.0) 57.2 (16.3) 60.0 (15.1) −2.6 (− 1.4–6.7)
ICU Admission, n (%) 220 (75) 161 (76) 59 (71) 5.2 (−5.9–16.3)
Fluids Administered over 24 h, liters (mean, SD) 4161 (2881) 4454 (2940) 3420 (2596) 1034 (307–1761)
Lactate, mmol/L (mean, SD) 3.2 (2.8) 3.0 (2.3) 3.9 (3.7) −0.9 (− 1.6–0.2)
Triage Vital Signs
Triage systolic blood pressure, mmHg (mean, SD) 108 (65) 109 (74) 106 (31) 3 (−13–19)
Triage heart rate, bpm (mean, SD) 107 (26) 109 (24) 103 (31) 6 (−1–12)
White blood cell count, cells/mL (mean, SD) 16.2 (10.2) 15.9 (10.1) 17.0 (10.3) −1.1 (−3.7–1.5)
ED Charges, Total, dollars (median, IQR) $3640 (2861 – 5234) $3840 (2947 – 5661) $3380 (2793 – 4356) 334 (71–653)
Hospital Facility Charges (median, IQR) $2776 (2232 – 3706) $2863 (2288 – 3772) $2574 (2049 – 3264) 264 (63–482)
Professional Fees (median, IQR) $760 (660–1496) $1050 (681–1950) $681 (660–1050) 19 (0–21)
Comorbidities
Peripheral vascular disease, n (%) 17 (6) 10 (5) 7 (8) −3.7 (− 9.7–2.3)
Paralysis, n (%) 17 (6) 14 (7) 3 (4) 3.0 (− 2.9–9.0)
Neurologic disorders, n (%) 35 (12) 27 (13) 8 (10) 3.2 (− 5.1–11.4)
COPD, n (%) 47 (16) 32 (15) 15 (18) −2.9 (− 12.3–6.4)
DM with complications, n (%) 23 (8) 20 (9) 3 (4) 5.9 (−1.0–12.7)
Hypothyroidism, n (%) 23 (8) 17 (8) 6 (7) 0.8 (−6.0–7.7)
Renal failure, n (%) 38 (13) 29 (14) 9 (11) 2.9 (−5.7–11.5)
Liver disease, n (%) 42 (14) 23 (11) 19 (23) −12.0 (−20.8 - -3.1)
Metastatic cancer, n (%) 18 (6) 11 (5) 7 (8) −3.2 (−9.3–2.9)
Solid tumor without metastasis, n (%) 16 (5) 8 (4) 8 (10) −5.8 (−11.6 - -0.1)
Coagulopathy, n (%) 53 (18) 30 (14) 23 (28) −13.4 (−23.2 - -3.7)
Fluid and electrolyte disorders, n (%) 231 (79) 153 (73) 78 (94) −21.4 (−31.7 - -11.3)
Deficiency anemia, n (%) 34 (12) 30 (14) 4 (5) 9.4 (1.2–17.5)
Hypertension, n (%) 96 (32) 7 (3) 5 (6) 17.0 (5.1–28.8)
APACHE-II score (mean, SD) 16.9 (7.0) 16.2 (6.5) 18.6 (7.8) −2.4 (−4.1 - -0.6)
28-day ICU-free days (median, IQR) 22 (0–26) 25 (22–26) 0 (0–0) 25 (24–25)
28-day hospital free days (median, IQR) 12 (0–21) 18 (10–22) 0 (0–0) 18 (17–20)
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Limitations
This study has several limitations. First, we used retrospect-
ively collected data from a single site. Although this may
limit the external validity of our finding, it reflects accurately
the way that this tool may be used in actual observational
analyses. For our data collection we looked at ED charges,
not actual cost to the patient. Costs are challenging to esti-
mate, so they often are estimated based on the cost-to-
charge ratio, and use of this ratio would be expected to
yield similar precision. As with all claims-based studies,
there is a bias towards identifying patients with more severe
illness [17]. The high mortality in this cohort, however, sup-
ports that severity was likely reflected accurately. Finally, as
a single-center study, we have no data on the concordance
between hospitals, which is an important consideration for
this method to be used on a large scale. Additionally, the
application of ED cost to predict mortality may not be ap-
plicable outside of the United States where charges are
more variable. Fortunately, studies that propose to use this
method can validate the association between ED charges
and clinical outcomes within the study, so using ED charges
as a covariate in a multivariable regression model will allow
one to assess its contribution to model fit in each applica-
tion independently.
This study also included only patients admitted to an in-
tensive care unit. These inclusion criteria were intended to
Fig. 1 Scatter plot comparing ED charges with APACHE-II scores
Fig. 2 Receiver operator characteristics (ROC) curve comparing three variables on their ability to predict survival: Elixhauser comorbidities, ED
charges, and APACHE-II scores
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limit the study population to those with greater severity of
illness, but it may limit the generalizability of the findings.
Conclusions
ED charges are a useful surrogate measure for severity of
illness in sepsis studies based on administrative data. ED
charges are inversely associated with mortality in severe
sepsis and septic shock, and they predict hospital and ICU
length-of-stay. ED charges may reflect both severity of ill-
ness and the contribution of ED care on clinical outcomes.
Future work should focus on the applicability of comparing
this covariate across hospital systems to adjust severity of
illness in large administrative data sets, and to use it in
other disease categories.
Abbreviations
APACHE-II: Acute Physiology and Chronic Health Evaluation, 2nd edition;
AUC: Area Under the Curve; BIC: Bayesian Information Criteria;
ED: Emergency Department; ICD-9: International Classification of Diseases,
9th Edition; ICU: Intensive Care Unit; SAPS: Simplified Acute Physiology Score;
SOFA: Sequential Organ Failure Assessment; STROBE: Strengthening the
Reporting of Observational Studies in Epidemiology
Funding
This project is supported by the Emergency Medicine Foundation, the
University of Iowa Department of Emergency Medicine, and the University of
Iowa Institute for Clinical and Translational Sciences, which is supported by
the National Institutes of Health (NIH) Clinical and Translational Science
Award (CTSA) program, grant U54TR001356. The organizations funding this
research did not have any access to data or contribute to the study design
or interpretation. The funding organization played no role in the acquisition,
analysis, or reporting of this research report. Dr. Mohr is also supported by a
grant from the Federal Office of Rural Health Policy. Dr. Fuller was funded by
the Washington University KL2 Career Development Award and (KL2
TR000450) from the National Center for Advancing Translational Sciences
(NCATS) and the Foundation for Barnes-Jewish Hospital Clinical and Transla-
tional Sciences Research Program (Grant # 8041–88).
Availability of data and materials
The datasets analyzed during the current study are available in de-identified
form from the corresponding author on reasonable request.
Authors’ contributions
NMM, RDP, and AA conceived the study, interpreted the analysis, and
drafted the manuscript. KKH conducted the analysis, interpreted the analysis,
and drafted critical portions of the manuscript. DS, BMF, and JCT contributed
to interpretation of the study findings and critically revised the manuscript.
DM, CM, and LK collected the research data, contributed to interpretation of
the analysis, and critically revised the manuscript. All authors read and
approved the final manuscript.
Ethics approval and consent to participate
This study was approved by the University of Iowa Institutional Review Board
(IRB # 201211702) under waiver of informed consent.
Consent for publication
Not applicable (no individually identifiable patient data are contained in this
manuscript).
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Emergency Medicine, University of Iowa College of
Medicine, 200 Hawkins Drive, 1008 RCP, Iowa City, IA 52246, USA. 2Division of
Critical Care, Department of Anesthesia, University of Iowa Carver College of
Medicine, 200 Hawkins Dr. 6546 JCP, Iowa City, IA 52246, USA. 3Department
of Health Management and Policy, University of Iowa College of Public
Health, N244 CPHB, Iowa City, IA 52246, USA. 4TeamHealth, St. Rose
Dominican Hospital-Siena Campus, Southern Hills Hospital and Medical
Center, 2380 W. Horizon Ridge Parkway, Ste 110, Henderson, NV 89052, USA.
5Division of Critical Care, Department of Anesthesiology, Division of
Emergency Medicine, Washington University School of Medicine, One
Brookings Drive, St. Louis, MO 63130, USA. 6Department of Epidemiology,
University of Iowa College of Public Health, S441A CPHB, Iowa City, IA 52246,
USA.
Received: 2 May 2018 Accepted: 7 December 2018
References
1. Kilgannon J, Jones AE, Shapiro NI, et al. Association between arterial
hyperoxia following resuscitation from cardiac arrest and in-hospital
mortality. JAMA. 2010;303(21):2165–71.
2. Tirschwell DL, Longstreth WT Jr. Validating administrative data in stroke
research. Stroke. 2002;33(10):2465–70.
3. Angus DC, van der Poll T. Severe Sepsis and septic shock. N Engl J Med.
2013;369(9):840–51.
4. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, et al. Incidence
and outcomes of acute lung injury. N Engl J Med. 2005;353(16):1685–93.
5. Rothberg MB, Pekow PS, Priya A, Zilberberg MD, Belforti R, Skiest D, et al.
Using highly detailed administrative data to predict pneumonia mortality.
PLoS One. 2014;9(1).
6. Strehlow MC, Emond SD, Shapiro NI, Pelletier AJ, Camargo CA, Jr. National
study of emergency department visits for sepsis, 1992 to 2001. Ann Emerg
Med 2006;48(3):326–331, 31.e1–3.
7. Berger T, Green J, Horeczko T, Hagar Y, Garg N, Suarez A, et al. Shock index
and early recognition of Sepsis in the emergency department: pilot study.
West J Emerg Med. 2013;14(2):168–74.
8. Thomas JW. Risk adjustment for measuring health care outcomes, 3rd
edition. Int J Qual Health Care. 2004;16(2):181–2.
9. Knaus WA, Zimmerman JE, Wagner DP, Draper EA, Lawrence DE. APACHE-
acute physiology and chronic health evaluation: a physiologically based
classification system. Crit Care Med. 1981;9(8):591–7.
10. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of
disease classification system. Crit Care Med. 1985;13(10):818–29.
11. Jones AE, Trzeciak S, Kline JA. The sequential organ failure assessment score
for predicting outcome in patients with severe sepsis and evidence of
hypoperfusion at the time of emergency department presentation. Crit Care
Med. 2009;37(5):1649–54.
12. Moreno RP, Metnitz PG, Almeida E, Jordan B, Bauer P, Campos RA, et al.
SAPS 3--from evaluation of the patient to evaluation of the intensive care
unit. Part 2: development of a prognostic model for hospital mortality at
ICU admission. Intensive Care Med. 2005;31(10):1345–55.
13. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use
with administrative data. Med Care. 1998;36(1):8–27.
14. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke
JP. The strengthening the reporting of observational studies in
epidemiology (STROBE) statement: guidelines for reporting observational
studies. Lancet (London, England). 2007;370(9596):1453–7.
15. Polderman KH, Girbes AR, Thijs LG, Strack van Schijndel RJ. Accuracy and
reliability of APACHE II scoring in two intensive care units problems and
pitfalls in the use of APACHE II and suggestions for improvement.
Anaesthesia. 2001;56(1):47–50.
16. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early
goal-directed therapy in the treatment of severe Sepsis and septic shock. N
Engl J Med. 2001;345(19):1368–77.
17. Whittaker SA, Mikkelsen ME, Gaieski DF, Koshy S, Kean C, Fuchs BD. Severe sepsis
cohorts derived from claims-based strategies appear to be biased toward a more
severely ill patient population. Crit Care Med. 2013;41(4):945–53.
Mohr et al. BMC Emergency Medicine           (2018) 18:62 Page 6 of 6
